
|Articles|April 1, 2003
Hair Removal Duet
San Francisco -- Topical eflornithine hydrochloride 13.9 percent cream (Vaniqa) can be used safely by patients undergoing laser hair removal and may have added value for improving the response to photoepilation, especially early on, according to results of a double-blinded study presented by Stacy R. Smith, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















